Solutions Needed To Create More Pharmaceutical Innovation Leading To Accessible Drugs

New York Times: A Dearth in Innovation for Key Drugs
Eduardo Porter, New York Times columnist

“…Antibiotics face a daunting proposition. They are not only becoming more difficult to develop, but they are also not obviously profitable. … Research on new antibiotics could be encouraged by allowing shorter clinical trials for the promising molecules or guaranteeing minimum returns for groundbreaking drugs. … At the same time, new mechanisms are needed to constrain prices…” (7/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.